REG - Syncona Limited - Result of AGM

SynconaAnnouncement

06/08/2024 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240806:nRSF4138Za&default-theme=true

RNS Number : 4138Z  Syncona Limited  06 August 2024

Syncona Limited

Result of Annual General Meeting

6 August 2024

At the Annual General Meeting of Syncona Limited (the "Company") held today,
all Resolutions as set out in the 'Notice of the 2024 Annual General Meeting'
dated 3 July 2024 sent to shareholders of the Company (the "Notice") were duly
passed.

Resolutions 1 to 12 were proposed as Ordinary Resolutions. Resolution 13 was
proposed as a Special Resolution and Resolution 14 was proposed as an
Extraordinary Resolution.

Details of the proxy voting results, which should be read alongside the
Notice, are noted below:

 No  Resolution                                                                                                           For          Discretion  Against    Abstain (withheld)
 1   Receive and consider the Annual Audited Financial Statements of the Company                                          487,893,906  (0)         8,329      516,479
     for the year ended 31 March 2024, together with the Reports of the Directors

     and Auditors therein                                                                                                 (99.99%)     (0%)        (0.01%)
 2   Re-appointment of Deloitte LLP (Guernsey Branch) as Auditors                                                         477,577,926  (0)         71,702     10,769,086

                                                                                                                          (99.98%)     (0%)        (0.02%)
 3   Authorise the Directors to determine the remuneration of the Auditors                                                477,634,135  (0)         21,314     10,763,265

                                                                                                                          (99.99%)     (0%)        (0.01%)
 4   Re-elect Melanie Gee as a Director                                                                                   485,153,484  (0)         2,748,702  516,528

                                                                                                                          (99.44%)     (0%)        (0.56%)
 5   Re-elect Julie Cherrington as a Director                                                                             487,856,391  (0)         45,795     516,528

                                                                                                                          (99.99%)     (0%)        (0.01%)
 6   Re-elect Cristina Csimma as a Director                                                                               487,826,744  (0)         75,442     516,528

                                                                                                                          (99.98%)     (0%)        (0.02%)
 7   Re-elect Virginia Holmes as a Director                                                                               485,146,832  (0)         2,755,354  516,528

                                                                                                                          (99.44%)     (0%)        (0.56%)
 8   Re-elect Robert Hutchinson as a Director                                                                             485,091,732  (0)         2,808,954  518,028

                                                                                                                          (99.42%)     (0%)        (0.58%)
 9   Re-elect Kemal Malik as a Director                                                                                   485,094,236  (0)         2,806,450  518,028

                                                                                                                          (99.42%)     (0%)        (0.58%)
 10  Re-elect Gian Piero Reverberi as a Director                                                                          485,095,482  (0)         2,806,704  516,528

                                                                                                                          (99.42%)     (0%)        (0.58%)
 11                                           Approve the report on implementation of the Remuneration Policy for         487,781,294  (0)         123,008    514,412
                                              Non-Executive Directors

                                                                                                                          (99.97%)     (0%)        (0.03%)
 12                                           Authority to allot and issue shares, as set out in the Notice               475,216,648  (0)         784,717    12,417,349

                                                                                                                          (99.84%)     (0%)        (0.16%)
 13                                           Authorise the Company to purchase its own shares, as set out in the Notice  487,879,475  (0)         27,221     512,018

                                                                                                                          (99.99%)     (0%)        (0.01%)
 14                                           Disapply pre-emption rights, as set out in the Notice                       469,084,312  (0)         6,914,778  12,419,624

                                                                                                                          (98.55%)     (0%)        (1.45%)

A vote withheld is not a vote in law and has not been counted in the votes for
and against a resolution.

In accordance with the UK Listing Rule 6.4.2R, a copy of all the resolutions
passed other than resolutions concerning ordinary business have been submitted
to the Financial Conduct Authority via the National Storage Mechanism and will
shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

The full text of the resolutions can be found in the Notice, a copy of which
is available on the Company's website at
https://www.synconaltd.com/investors/shareholder-information/shareholder-documents/
(https://www.synconaltd.com/investors/shareholder-information/shareholder-documents/)
.

Enquiries

Syncona Limited

Natalie Garland-Collins / Fergus Witt

Tel: +44 (0) 20 3981 7940

 

FTI Consulting

Ben Atwell / Tim Stamper

Tel: +44 (0) 20 3727 1000

 

About Syncona:

Syncona's purpose is to invest to extend and enhance human life. We do this by
creating, building and scaling companies to deliver transformational
treatments to patients in areas of high unmet need.

We aim to build and maintain a diversified portfolio of 20-25 globally leading
life science businesses, across development stage, modality and therapeutic
area, for the benefit of all our stakeholders. We focus on developing
treatments that deliver patient impact by working in close partnership with
world-class academic founders and experienced management teams. Our balance
sheet underpins our strategy, enabling us to take a long-term view as we look
to improve the lives of patients with no or poor treatment options, build
sustainable life science companies and deliver strong risk-adjusted returns to
shareholders.

 

Syncona Limited seeks to achieve returns over the long term. Investors should
seek to ensure they understand the risks and opportunities of an investment in
Syncona Limited, including the information in our published documentation,
before investing.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUPUMURUPCGWQ